Investing the Chief Medical Officer of the Nexylin technology has purchased $ 7,700.

David Osous, Boss Treatment (TASE 🙂 Officer of Nexalin Technology Inc. (NASDAQ :), the total number of $ 7,700 valuablely valuable stock purchase. Although compared to the last year, the stock has reduced about 18% of the context, which is known for the last week, it is known. The transactions were performed in January 13 and January 23, and Oores received 3,000 stocks. The stocks purchased by stock of 2.50 to $ 2.70 and below $ 2.72 in the current marketing price. Ounus, following these purchases, contains 152,293 stocks in the $ 33.4 million market company. These transactions emphasize Owns on Omns, which protects an accurate financial health point in accordance with the stockpro.

In other recent news, Nixaiclic technology, ink, the Inquisition of Intensism The investment of nerding, is a big chapter, the CEO of Company Mark White. This development improves the visions of the Nixasslin and the international control acceleration. The company has successfully met the equity requirements of nstadian shareholderships by raising $ 5.25 million.

Five directors are selected from Board, five directors of the recent-day stock owner meeting, and this indicates that Mark ELP has been an approved public account management organization for the coming fiscal year. However, the company announced that the highest vice President of Clinical, quality and control affairs Michael’s ceremony.

In production in production field, NixSalin accepted the Gen-2 15 Milliamp Neuros and China recently accepted by Oman and Chinese. These are the latest developments in Nexylin technology. The company did not promise to update these future statements more than the press release date.

This article is created by AI support and is estimated by editor. See our T & C for more information.